Navigation Links
Questcor Reports 2010 Financial Results
Date:2/23/2011

ANAHEIM, Calif., Feb. 23, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the full year and fourth quarter ended December 31, 2010.

For the year ended December 31, 2010, net sales increased 30.4 percent to a record $115.1 million from $88.3 million in the prior year.  The Company's financial performance was driven by an increase in net sales for H.P. Acthar® Gel (Acthar), for the treatment of acute exacerbations of multiple sclerosis (MS).  Full year 2010 net income was $35.1 million, or $0.54 per diluted common share.  Net income for 2009 was $26.6 million, or $0.40 per diluted common share.

"Strong gains in MS prescriptions throughout 2010 drove record net sales for Acthar and Questcor," said Don M. Bailey, President and CEO of Questcor. "Our number one focus in 2010, as it will be again in 2011, was the growth of MS prescriptions for Acthar.  In the fourth quarter, we expanded our MS sales force for the fourth time. Each of the previous expansions resulted in significantly increased sales.  We expect MS sales to continue to grow in 2011."

"Also in the fourth quarter, the FDA approved our sNDA for infantile spasms (IS) and modernized the label for Acthar, so that the label now includes 19 approved indications. This development allowed us to begin promotion of Acthar in IS as well as for the on-label indications associated with nephrotic syndrome (NS)," added Mr. Bailey.

"Despite the disruption caused by doubling our sales force, new shipped MS Acthar prescriptions so far in the first quarter of 2011 are running slightly ahead of the pace in the fourth quarter and well ahead of the pace in the first quarter of 2010," continued Mr. Bailey.  "Also in the first quarter we are initiating an in-depth commercial exploration of the on-label opportunity for Acthar in NS.
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
2. Questcor Pharmaceuticals Reports Strong Finish to 2010
3. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
4. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
5. Questcor to Present at the Maxim Group Growth Conference
6. Questcor Reports Third Quarter 2010 Results
7. Questcor to Present at the 21st Annual Oppenheimer Healthcare Conference
8. Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
9. Questcor and Child Neurology Foundation Support the 2nd Annual Infantile Spasms (IS) Awareness Week
10. Questcor to Present at UBS Global Life Sciences Conference
11. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2013)... -- Novation, the leading health care supply chain expertise, analytics ... new design specifications to significantly reduce tubing misconnections which ... health care supply chain and patient safety. ... typical patient could be connected via tubes or catheters ... fluids. A universal tube connector, commonly known as a ...
(Date:12/18/2013)... , Dec. 18, 2013   Temptime Corporation ... to the health care industry, announced today that ... -based William Laboratories  to expand into blood ... step toward expanding its capabilities since it partnered ... , a strategic investor focused exclusively on health ...
(Date:12/18/2013)... DIEGO , Dec. 18, 2013 BioMed Realty ... appointment of Dr. William R. Brody , President of ... directors, increasing the board to nine members. ... to our board," said Alan D. Gold , Chairman ... internationally for his accomplishments in biomedical engineering, including over 100 ...
Breaking Medicine Technology:Novation Among Leaders Developing New Standards to Prevent Tubing Misconnections 2Novation Among Leaders Developing New Standards to Prevent Tubing Misconnections 3Temptime Acquires William Laboratories to Expand into Blood Temperature Monitoring Solutions 2BioMed Realty Trust Appoints Dr. William R. Brody, President Of The Salk Institute, To Its Board Of Directors 2BioMed Realty Trust Appoints Dr. William R. Brody, President Of The Salk Institute, To Its Board Of Directors 3
... Incorporated (NASDAQ: VPHM ) today announced the ... ILNS) to its clinical stage drug candidate, OX1, being ... rare, hereditary, progressive neurodegenerative disease. OX1, ... molecule that has potent anti-oxidant properties that can protect ...
... KIRKLAND, Wash., Sept. 29, 2011 Cardiac Dimensions®, Inc. ... Mark approval for a newly enhanced version of its ... heart failure patients suffering from functional mitral regurgitation (FMR). ... initiate a commercial launch of the enhanced device in ...
Cached Medicine Technology:ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreich's Ataxia 2ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreich's Ataxia 3ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreich's Ataxia 4Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™ 2Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™ 3
(Date:12/18/2013)... 18, 2013 MarketsandMarkets recently conducted ... Market [ by Transportation Management, Transportation Control Systems, ... Management, Remote Sensing, Electronic Access, Display] - Worldwide ... analyzed and studied the major market drivers, restraints, ... Middle East and Africa (MEA), Asia Pacific including ...
(Date:12/18/2013)... - Nearly two-thirds (65 percent) of the nation,s leading ... system will be somewhat or significantly better by 2020 ... health care reform. Additionally, 93 percent believe that the ... health system will improve during that time period. The ... on the Health Affairs Blog, by researchers ...
(Date:12/18/2013)... 2013 Golfers got to enjoy this ... Country Club thanks in part to MedCenter TMJ. Dr. ... hole during the local tournament, which was also a ... MedCenter TMJ often gives back to local ... event that Dr. Auvenshine himself enjoys participating in. "My ...
(Date:12/18/2013)... 18, 2013 (December 18, 2013) ... bring you six key ingredients to support the immune ... has expanded its retail partners in advance of the ... video campaign on Youtube. , IMMUNO GUM® ... Miami International Airport (MIA), where the company expects the ...
(Date:12/18/2013)... City, Utah (PRWEB) December 18, 2013 ... small business health benefits solution, published new information ... . , According to Zane Benefits’ website, here's ... the major health care reform provisions taking effect ... essential health benefits, the health insurance exchanges, individual ...
Breaking Medicine News(10 mins):Health News:Transportation Systems and Analytics (Roadways, Railways, Airways, Seaways) Market Worth $57.46 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Transportation Systems and Analytics (Roadways, Railways, Airways, Seaways) Market Worth $57.46 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Transportation Systems and Analytics (Roadways, Railways, Airways, Seaways) Market Worth $57.46 Billion by 2018 - New Report by MarketsandMarkets 4Health News:Leading health care executives optimistic about health care reform, Penn survey shows 2Health News:Leading health care executives optimistic about health care reform, Penn survey shows 3Health News:MedCenter TMJ Shows Support for Local Golf Course During the Sweet Shot Tournament 2Health News:IMMUNO GUM Gears Up For Cold - Flu Season With New Retail Stores And YouTube Campaign 2Health News:Zane Benefits Publishes New Information on Upcoming Changes due to Health Reform 2
... 10 "The Senate compromise version of H.R. 1, ... no relief to the thousands of state and local ... economic downturn - including those who work in laboratories," ... Public Health Laboratories. "Unfortunately, the Senate has decided that ...
... Inc. (NYSE: NTY ) ( www.NBTY.com ), a leading global manufacturer and marketer of nutritional supplements, today announced the following preliminary unaudited ... NET SALES, ... FOR THE ... ($In Millions), ...
... Potential sale increases focus on growing core businessesCHICAGO, Feb. ... that it has reached an agreement in principle, subject ... to sell its Medication Services business. Closing of the ... conditions, but no assurances can be given that a ...
... as HPV tweak their DNA to escape detection, study ... of cancer-related viruses may actually change to disguise themselves from ... international team of scientists studied the entire genomes of three ... hepatitis B. Each of these pathogens can progress into cancer ...
... even if you stop taking the drug, study finds , , ... aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to reduce ... cancer. , That,s the conclusion of a new study of ... clear, and arguably proven, that NSAID drugs do interfere with ...
... of the Center for Research on Minority Health ... Member for NPAF and PAF, Honored for His ... Feb. 10 The National Patient Advocate Foundation ... that a member of the Foundations, Executive Boards, ...
Cached Medicine News:Health News:Laid Off Public Health Workers Excluded From Senate Stimulus, Governmental Health Laboratories Slammed by Recession 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results for January 2009 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results for January 2009 3Health News:Allscripts Announces Agreement in Principle to Sell Its Medication Services Business 2Health News:Allscripts Announces Agreement in Principle to Sell Its Medication Services Business 3Health News:Genes Help Cancer-Linked Viruses Elude Immune System 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 3Health News:Executive Board Member of National Patient Advocate Foundation, Patient Advocate Foundation Receives National Institutes of Health 2008 Health Disparities Excellence Award 2Health News:Executive Board Member of National Patient Advocate Foundation, Patient Advocate Foundation Receives National Institutes of Health 2008 Health Disparities Excellence Award 3
DUALSWITCH-SHUNTSYSTEM for L-P-Derivation...
26 cm - 10 1/4, 140 mm - 5 1/2, bayonet-shaped, flexible, 90 angle, 4 mm...
Toothed pituitary rongeur....
Wilson pituitary forcep, flattened tip, 3 mm bite, 145 mm effective....
Medicine Products: